Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro
<p>Abstract</p> <p>Background</p> <p>Genetic redirection of lymphocytes that have been genetically engineered to recognize antigens other than those originally programmed in their germlines is a potentially powerful tool for immunotherapy of cancers and potentially also...
Main Authors: | Kolokoltsov Andrey A, Whitehead Robert P, Simmons Anthony, Davey Robert A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-02-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/3/1/8 |
Similar Items
-
Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors.
by: Lipinski, D, et al.
Published: (2014) -
Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing
by: Mai Izumida, et al.
Published: (2020-04-01) -
A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
by: Takeshi Saito, et al.
Published: (2020-08-01) -
Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
by: Sarah Moeschler, et al.
Published: (2016-09-01) -
Towards a first-in-human trial with a pseudotyped lentivirus
by: Alton, EW, et al.
Published: (2020)